{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T22:01:52Z","timestamp":1722895312124},"reference-count":52,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7529","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T10:23:21Z","timestamp":1556187801000},"source":"Crossref","is-referenced-by-count":3,"title":["Enterovirus type 71\u2011immunized chicken egg yolk immunoglobulin has cross antiviral activity against coxsackievirus A16 in\ufffdvitro"],"prefix":"10.3892","author":[{"given":"Enyi","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Guilin Medical University, Guilin, Guangxi 541000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuwen","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of State Key Laboratory of Virology, School of Life Sciences, Wuhan University, Wuhan, Hubei 430000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Guilin Medical University, Guilin, Guangxi 541000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonglian","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Guilin Medical University, Guilin, Guangxi 541000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Guilin Medical University, Guilin, Guangxi 541000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songqing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Guilin Medical University, Guilin, Guangxi 541000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Guilin Medical University, Guilin, Guangxi 541000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingchen","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Guilin Medical University, Guilin, Guangxi 541000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"key20200713100158_b1-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"key20200713100158_b2-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"19780","DOI":"10.3402\/ehtj.v6i0.19780","article-title":"Human enterovirus 71 epidemics: What's next?","volume":"6","author":"Yip","year":"2013","journal-title":"Emerg Health Threats J"},{"key":"key20200713100158_b3-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/rmv.1827","article-title":"Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014","volume":"25","author":"Liu","year":"2015","journal-title":"Rev Med Virol"},{"key":"key20200713100158_b4-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1099\/jgv.0.000780","article-title":"Human picornaviruses associated with neurological diseases and their neutralization by antibodies","volume":"98","author":"Anastasina","year":"2017","journal-title":"J Gen Virol"},{"key":"key20200713100158_b5-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"key20200713100158_b6-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1056\/NEJM196305092681904","article-title":"Fatal infection in an infant associated with Coxsackie virus group A, type 16","volume":"268","author":"Wright","year":"1963","journal-title":"N Engl J Med"},{"key":"key20200713100158_b7-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3201\/eid1307.070295","article-title":"Fatal coxsackievirus A-16 pneumonitis in adult","volume":"13","author":"Legay","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"key20200713100158_b8-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3201\/eid1510.090594","article-title":"Rhombencephalitis and coxsackievirus A16","volume":"15","author":"Goto","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key20200713100158_b9-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/01.inf.0000115950.63906.78","article-title":"Fatal coxsackievirus A16 infection","volume":"23","author":"Wang","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"key20200713100158_b10-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jcv.2015.01.007","article-title":"Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults: Rhinovirus among adults and children","volume":"64","author":"Chen","year":"2015","journal-title":"J Clin Virol"},{"key":"key20200713100158_b11-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"key":"key20200713100158_b12-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1479-0556-5-6","article-title":"DNA vaccine constructs against enterovirus 71 elicit immune response in mice","volume":"5","author":"Tung","year":"2007","journal-title":"Genet Vaccines Ther"},{"key":"key20200713100158_b13-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","article-title":"Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide","volume":"9","author":"Foo","year":"2007","journal-title":"Microbes Infect"},{"key":"key20200713100158_b14-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1016\/j.vaccine.2012.09.030","article-title":"Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach","volume":"30","author":"Kirk","year":"2012","journal-title":"Vaccine"},{"key":"key20200713100158_b15-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"key":"key20200713100158_b16-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"6447","DOI":"10.1039\/C6CC02595A","article-title":"Alumina-encapsulated vaccine formulation with improved thermostability and immunogenicity","volume":"52","author":"Zhou","year":"2016","journal-title":"Chem Commun (Camb)"},{"key":"key20200713100158_b17-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1086\/649012","article-title":"Presence of high-titer neutralizing antibodies against enterovirus 71 in intravenous immunoglobulin manufactured from Chinese donors","volume":"50","author":"Cao","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key20200713100158_b18-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00705-011-1222-6","article-title":"In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection","volume":"157","author":"Zhang","year":"2012","journal-title":"Arch Virol"},{"key":"key20200713100158_b19-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.4161\/hv.21739","article-title":"Production of EV71 vaccine candidates","volume":"8","author":"Chong","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"key20200713100158_b20-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1016\/j.vaccine.2016.02.077","article-title":"Status of research and development of vaccines for enterovirus 71","volume":"34","author":"Reed","year":"2016","journal-title":"Vaccine"},{"key":"key20200713100158_b21-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1002\/jmv.24847","article-title":"Epidemiological and genetic analysis concerning the non-enterovirus 71 and non-coxsackievirus A16 causative agents related to hand, foot and mouth disease in Anyang city, Henan Province, China, from 2011 to 2015","volume":"89","author":"Li","year":"2017","journal-title":"J Med Virol"},{"key":"key20200713100158_b22-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1016\/j.vaccine.2009.03.060","article-title":"Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007","volume":"27","author":"Mizuta","year":"2009","journal-title":"Vaccine"},{"key":"key20200713100158_b23-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1743-422X-7-94","article-title":"An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol J"},{"key":"key20200713100158_b24-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02834.x","article-title":"Clinical uses of intravenous immunoglobulin","volume":"142","author":"Jolles","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"key20200713100158_b25-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-2249.2004.02412.x","article-title":"Increased risk of adverse events when changing intravenous immunoglobulin preparations","volume":"136","author":"Ameratunga","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"key20200713100158_b26-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1743-422X-8-106","article-title":"Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo","volume":"8","author":"Han","year":"2011","journal-title":"Virol J"},{"key":"key20200713100158_b27-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/clpt.2008.170","article-title":"Monoclonal antibody pharmacokinetics and pharmacodynamics","volume":"84","author":"Wang","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"key20200713100158_b28-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0300-483X(95)03123-W","article-title":"Side-effects of a monoclonal antibody, muromonab CD3\/orthoclone OKT3: Bibliographic review","volume":"105","author":"Sgro","year":"1995","journal-title":"Toxicology"},{"key":"key20200713100158_b29-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S1095-6433(01)00508-6","article-title":"Generation and application of chicken egg-yolk antibodies","volume":"131","author":"Tini","year":"2002","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"key20200713100158_b30-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jim.2012.06.001","article-title":"Stability of orally administered immunoglobulin in the gastrointestinal tract","volume":"384","author":"Lee","year":"2012","journal-title":"J Immunol Methods"},{"key":"key20200713100158_b31-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/00071668.2011.646951","article-title":"IgY stability in eggs stored at room temperature or at + 4\u00b0C","volume":"53","author":"Nilsson","year":"2012","journal-title":"Br Poult Sci"},{"key":"key20200713100158_b32-etm-0-0-7529","first-page":"925","article-title":"The production of avian (Egg Yolk) Antibodies: IgY","volume":"24","author":"Schade","year":"1997","journal-title":"ATLA"},{"key":"key20200713100158_b33-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3382\/ps.2011-01757","article-title":"Hatching egg and newly hatched chick yolk sac total IgY content at 3 broiler breeder flock ages","volume":"91","author":"Ulmer-Franco","year":"2012","journal-title":"Poult Sci"},{"key":"key20200713100158_b34-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S1359-6446(03)02655-2","article-title":"The use of gene-specific IgY antibodies for drug target discovery","volume":"8","author":"Zhang","year":"2003","journal-title":"Drug Discov Today"},{"key":"key20200713100158_b35-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5625\/lar.2012.28.1.55","article-title":"Anti-Helicobacter pylori effects of IgY from egg york of immunized hens","volume":"28","author":"Yang","year":"2012","journal-title":"Lab Anim Res"},{"key":"key20200713100158_b36-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jnma.2017.04.001","article-title":"Anti-Vibriocholerae IgY antibody inhibits mortality in suckling mice model","volume":"110","author":"Akbari","year":"2018","journal-title":"J Natl Med Assoc"},{"key":"key20200713100158_b37-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5851\/kosfa.2017.37.1.1","article-title":"Chicken Egg Yolk antibodies (IgY) for prophylaxis and treatment of rotavirus diarrhea in human and animal neonates: A concise review","volume":"37","author":"Thu","year":"2017","journal-title":"Korean J Food Sci Anim Resour"},{"key":"key20200713100158_b38-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jviromet.2005.10.027","article-title":"Preparation and evaluation of anti-SARS coronavirus IgY from yolks of immunized SPF chickens","volume":"133","author":"Fu","year":"2006","journal-title":"J Virol Methods"},{"key":"key20200713100158_b39-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1373\/clinchem.2008.120576","article-title":"Cell lines as candidate reference materials for quality control of ERBB2 amplification and expression assays in breast cancer","volume":"55","author":"Xiao","year":"2009","journal-title":"Clin Chem"},{"key":"key20200713100158_b40-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0166-0934(98)00178-5","article-title":"A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody","volume":"78","author":"Lee","year":"1999","journal-title":"J Virol Method"},{"key":"key20200713100158_b41-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.12659\/MSM.900380","article-title":"Virus-like particles produced in pichia pastoris induce protective immune responses against coxsackievirus A16 in mice","volume":"22","author":"Feng","year":"2016","journal-title":"Med Sci Monit"},{"key":"key20200713100158_b42-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of Enterovirus 71","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"key20200713100158_b43-etm-0-0-7529","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001\u20132007","volume":"38","author":"Ang","year":"2009","journal-title":"Ann Acad Med Singapore"},{"key":"key20200713100158_b44-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nsmb.2255","article-title":"A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71","volume":"19","author":"Wang","year":"2012","journal-title":"Nat Struct Mol Biol"},{"key":"key20200713100158_b45-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"e1006625","DOI":"10.1371\/journal.ppat.1006625","article-title":"A highly conserved amino acid in VP1 regulates maturation of enterovirus 71","volume":"13","author":"Zhang","year":"2017","journal-title":"PLoS Pathog"},{"key":"key20200713100158_b46-etm-0-0-7529","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1128\/JVI.71.12.9743-9752.1997","article-title":"Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: The structure of empty capsids of foot-and-mouth disease virus","volume":"71","author":"Curry","year":"1997","journal-title":"J Virol"},{"key":"key20200713100158_b47-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.virol.2018.07.010","article-title":"Cleavages at the three junctions within the foot-and-mouth disease virus capsid precursor (P1-2A) by the 3C protease are mutually independent","volume":"522","author":"Kristensen","year":"2018","journal-title":"Virology"},{"key":"key20200713100158_b48-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/cid\/ciu852","article-title":"Review of enterovirus 71 vaccines","volume":"60","author":"Chong","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key20200713100158_b49-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"e29751","DOI":"10.1371\/journal.pone.0029751","article-title":"Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection","volume":"7","author":"Lim","year":"2012","journal-title":"PLoS One"},{"key":"key20200713100158_b50-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/10966200260398198","article-title":"Chicken egg yolk antibodies as therapeutics in enteric infectious disease: A review","volume":"5","author":"Mine","year":"2002","journal-title":"J Med Food"},{"key":"key20200713100158_b51-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.micpath.2017.03.025","article-title":"In vitro evaluation of cross-strain inhibitory effects of IgY polyclonal antibody against H. pylori","volume":"110","author":"Solhi","year":"2017","journal-title":"Microb Pathog"},{"key":"key20200713100158_b52-etm-0-0-7529","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12937-015-0067-3","article-title":"IgY antibodies in human nutrition for disease prevention","volume":"14","author":"M\u00fcller","year":"2015","journal-title":"Nutr J"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:31:07Z","timestamp":1694827867000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":52,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7529","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]}}}